NOVARTIS INDIA
Smallcap | BSE
Sector
Index
Here's the live share price of Novartis India along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-2.49₹ -30.10
As on May 18, 2026, 03:00 PM IST
Novartis India Price Performance
Today's LowToday's High
₹1,167.85₹1,225.90
₹1,178.70
52 Weeks' Low52 Weeks' High
₹750.00₹1,275.00
₹1,178.70
Open Price
₹1,189.95
Prev. Close
₹1,208.80
Volume
2,502
Novartis India Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Novartis India | 7.49 | 19.63 | 44.93 | 45.87 | 37.50 | 19.84 | 13.36 |
| Sun Pharmaceutical Industries | 2.78 | 12.14 | 11.70 | 7.65 | 9.44 | 26.31 | 22.55 |
| Divi's Laboratories | 1.37 | 7.99 | 10.51 | 4.25 | 8.26 | 27.53 | 10.96 |
| Torrent Pharmaceuticals | 0.80 | 6.23 | 3.64 | 15.68 | 35.25 | 39.60 | 26.14 |
| Cipla | 6.21 | 16.31 | 5.58 | -6.82 | -4.55 | 15.79 | 10.19 |
| Dr. Reddy's Laboratories | 3.14 | 9.22 | 5.09 | 7.18 | 8.40 | 13.88 | 4.90 |
| Mankind Pharma | 2.67 | 18.40 | 19.69 | 11.01 | -2.97 | 22.41 | 11.84 |
| Lupin | -5.73 | -3.65 | 0.95 | 9.26 | 8.38 | 41.57 | 13.52 |
| Zydus Lifesciences | 5.69 | 5.66 | 9.05 | 6.21 | 9.89 | 24.35 | 10.16 |
| Aurobindo Pharma | 1.22 | 8.70 | 27.15 | 21.78 | 25.36 | 32.89 | 8.50 |
| Laurus Labs | 8.09 | 17.64 | 31.21 | 29.99 | 120.42 | 61.58 | 22.96 |
| Biocon | 11.92 | 21.49 | 12.01 | 1.09 | 25.45 | 20.05 | 2.00 |
| Glenmark Pharmaceuticals | -1.27 | 3.77 | 14.91 | 25.12 | 61.29 | 56.64 | 31.04 |
| Alkem Laboratories | -2.74 | -2.58 | -1.03 | -5.23 | 3.88 | 16.69 | 12.72 |
| Abbott India | 3.73 | 6.93 | 5.06 | -6.58 | -9.51 | 9.32 | 11.25 |
| Anthem Biosciences | 0.08 | 8.64 | 14.05 | 17.99 | 7.50 | 2.44 | 1.46 |
| Ipca Laboratories | 6.46 | 13.05 | 10.13 | 12.92 | 18.64 | 33.73 | 8.68 |
| GlaxoSmithKline Pharmaceuticals | -3.95 | -1.35 | -8.16 | -4.20 | -15.60 | 22.75 | 9.47 |
| Ajanta Pharma | 6.09 | 13.74 | 9.33 | 28.50 | 23.61 | 36.40 | 19.74 |
| Gland Pharma | 12.36 | 23.26 | 18.27 | 17.92 | 45.75 | 16.51 | -5.19 |
Over the last one year, Novartis India has gained 37.50% compared to peers like Sun Pharmaceutical Industries (9.44%), Divi's Laboratories (8.26%), Torrent Pharmaceuticals (35.25%). From a 5 year perspective, Novartis India has outperformed peers relative to Sun Pharmaceutical Industries (22.55%) and Divi's Laboratories (10.96%).
Novartis India Financials
Novartis India Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,216.97 | 1,194.63 |
| 10 | 1,137.36 | 1,153.3 |
| 20 | 1,069.45 | 1,098.28 |
| 50 | 1,002.69 | 1,016.74 |
| 100 | 907.44 | 956.05 |
| 200 | 895.61 | 924.07 |
Novartis India Share Holding Pattern
In the latest quarter, Novartis India remained same as its previous close in promoter holding, while DII stake decreased to 0.53%, FII holding fell to 0.17%, and public shareholding moved up to 28.60% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Novartis India Corporate Actions
Date Time | Announcement |
|---|---|
| May 15, 2026, 11:37 PM IST IST | Novartis - Corrigendum To The Notice Of Postal Ballot Issued On April 16, 2026, For The Appointment Of Ms. Gowree Gokhale (DI |
| May 12, 2026, 08:13 PM IST IST | Novartis - Integrated Financial Results For The Quarter And Financial Year Ended March 31, 2026. |
| May 12, 2026, 07:37 PM IST IST | Novartis - Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday, May 12, 2026 To Approve The Audited Financ |
| Apr 16, 2026, 10:53 PM IST IST | Novartis - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot |
| Apr 13, 2026, 09:47 PM IST IST | Novartis - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
About Novartis India
Novartis India Ltd. is a Public Limited Listed company incorporated on 13/12/1947 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24200MH1947PLC006104 and registration number is 006104. Currently Company is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company's Total Operating Revenue is Rs. 354.33 Cr. and Equity Capital is Rs. 12.34 Cr. for the Year ended 31/03/2026.
- IndustryPharmaceuticals
- AddressInspire - BKC, 7th Floor, Mumbai Maharashtra 400051
- Contact
Management
- Mr. Christopher SnookChairperson
- Mrs. Shilpa JoshiWholeTime Director & CFO
- Mr. Falin MajmudarWhole Time Director
- Mr. Sandra MartyresIndependent Director
- Mr. Sanker ParameswaranIndependent Director
- Mr. Gira SardesaiIndependent Director
FAQs on Novartis India Share Price
What is the share price of Novartis India?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Novartis India is ₹1,178.70 as on May 18, 2026.
What kind of stock is Novartis India?
The Novartis India is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Novartis India?
The market cap of Novartis India is ₹2,910.30 Cr as on May 18, 2026.
What are today's High and Low prices of Novartis India?
Today’s highest and lowest price of Novartis India are ₹1,225.90 and ₹1,167.85.
What are the 52 Week High and 52 Week Low of Novartis India?
The 52-week high/low is the highest and lowest price at which Novartis India stock has traded in the past 52-week or nearly a year. The 52-week high of Novartis India is ₹1,275.00 and 52-week low of Novartis India is ₹750.00 as on May 18, 2026.
How has the Novartis India performed historically in terms of returns?
The Novartis India has shown returns of -2.49% over the past day, 17.91% for the past month, 42.85% over 3 months, 35.52% over 1 year, 19.24% across 3 years, and 13.02% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Novartis India?
P/E ratio of and PB ratio of Novartis India are 31.23 and 3.68 on May 18, 2026. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse